Cytodyn Inc (CYDY)

[MelsDollars]

The bottom line is Amarex had two years to finish the BLA, and didn't even correct the formatting issues, or the problems the FDA raised in their earlier letter. CRO's have control over what data the company can see and what they can't, so to claim that CYDY should have known about these issues is incorrect. They have to rely on the CRO. For whatever reason, Amarex failed to perform. Their failures have damaged Cytodyn and the shareholders.

I can appreciate Pourhassen's frustration that the BLA wasn't completed in the timeframe promised. Cytodyn was allowed to submit the BLA in sections, so he may not have known the condition of the dataset. I don't fault him for trying to protect the share price and get it going. I am happy that Recknor was hired and they are moving forward with more hands on deck to oversee the process.